| abstract |
The present invention is about 0.8% w/w to about 1% w/w docetaxel, about 30% w/w to about 38% w/w soybean phosphatidyl choline, about 0.2% w/w to about 0.8% w/w It comprises a sodium cholesteryl sulfate, about 61% w/w to about 68% w/w of sucrose and a pH adjusting agent, wherein the composition has a pH of less than 3.5, and a pharmaceutical liposome composition. |